Nevertheless, reports on the prognostic impact of HER4 in luminal BC are partially inconsistent and a tumor-suppressive impact of HER4 in (luminal) BC has also been reported both in the experimental [16] and the clinical setting [17]. The gene discussed is ERBB4; the disease is breast cancer.